Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved
- PMID: 37878045
- DOI: 10.1007/s00210-023-02791-0
Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved
Abstract
Nebivolol could prevent dysfunction in patients suffering myocardial ischemia. However, influence of hyperthyroidism is not known. Consequences and mechanisms of nebivolol treatment were investigated in isolated hearts from euthyroid (EuT) and hyperthyroid (HpT) rats. Rats were orally treated during 1 week with 20 mg/kg/day nebivolol (O-Neb), 30 mg/kg/day atenolol (O-Ate), or not treated (C). Isolated perfused hearts were exposed to global ischemia and reperfusion (I/R) inside a flow calorimeter. Left diastolic ventricular pressure, developed contractile pressure (P), and total heat rate (Ht) were continuously measured, while infarct size was measured after 2-h R. EuT-C and HpT-C hearts developed similarly low post-ischemic contractile recovery and economy (P/Ht). Nebivolol totally prevented dysfunction and reduced infarction size in EuT hearts, but partially improved recovery in HpT rat hearts. Contrarily, oral atenolol totally prevented dysfunction in HpT hearts but partially in EuT hearts. Nebivolol effects were reversed by perfusing L-NAME in both conditions, but partially reduced by aminoguanidine in HpT. However, L-NAME increased P and P/Ht recoveries in EuT-C and HpT-C rat hearts, as well as melatonin. Oral nebivolol prevented post-ischemic dysfunction and infarction in EuT hearts due to adrenergic β1 blockade and activation of iNOS and/or eNOS, but the effect was attenuated in HpT hearts by excessive iNOS-dependent nitrosative pathways.
Keywords: Atenolol; Cardioprotection; Hyperthyroidism; Melatonin; NO-synthases; Nebivolol.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Cardioprotective effect of hyperthyroidism on the stunned rat heart during ischaemia-reperfusion: energetics and role of mitochondria.Exp Physiol. 2015 Jun;100(6):680-97. doi: 10.1113/EP085063. Exp Physiol. 2015. PMID: 25854703
-
Amiodarone oral subacute treatment prevents cardiac dysfunction of ischemia/reperfusion in rats: Mechanisms and influence of hypothyroidism.Eur J Pharmacol. 2025 Jul 15;999:177677. doi: 10.1016/j.ejphar.2025.177677. Epub 2025 Apr 26. Eur J Pharmacol. 2025. PMID: 40294776
-
Cardioprotective Mechanisms of Hypothyroidism on Ischemia/Reperfusion in Rats and Effects of Carvedilol: Energetic Study.J Cardiovasc Pharmacol Ther. 2020 Jan;25(1):72-85. doi: 10.1177/1074248419872957. Epub 2019 Sep 8. J Cardiovasc Pharmacol Ther. 2020. PMID: 31495205
-
Different effects of selective β1-adrenoceptor antagonists, nebivolol or atenolol in acetaminophen-induced hepatotoxicity of rats.Fundam Clin Pharmacol. 2017 Apr;31(2):165-173. doi: 10.1111/fcp.12253. Epub 2017 Feb 16. Fundam Clin Pharmacol. 2017. PMID: 27862262
-
Mitochondrial Bioenergetics During Ischemia and Reperfusion.Adv Exp Med Biol. 2017;982:141-167. doi: 10.1007/978-3-319-55330-6_8. Adv Exp Med Biol. 2017. PMID: 28551786 Review.
References
-
- Al Habeeb W, Mrabeti S, Abdelsalam AAI (2022) Therapeutic properties of highly selective β-blockers with or without additional vasodilator properties: focus on bisoprolol and nebivolol in patients with cardiovascular disease. Cardiovasc Drugs Ther 36(5):959–971. https://doi.org/10.1007/s10557-021-07205-y - DOI
-
- Ambrosio G, Flather MD, Böhm M, Cohen-Solal A, Murrone A, Mascagni F, Spinucci G, Conti MG, van Veldhuisen DJ, Tavazzi L, Coats AJS (2011) β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. Heart 97(3):209–214. https://doi.org/10.1136/hrt.2010.207365 - DOI - PubMed
-
- Audigane L, Persello A, Piriou N, Ferron M, Trochu J-N, Lauzier B, Gauthier C, Rozec B (2021) Early nebivolol treatment is beneficial in myocardial infarction in rats partly through β3-adrenoceptor remodelling. Clin Exp Pharmacol Physiol 48(7):1007–1015. https://doi.org/10.1111/1440-1681.13447 - DOI - PubMed
-
- Bermudez-Gonzalez JL, Sanchez-Quintero D, Proaño-Bernal L, Santana-Apreza R, Jimenez-Chavarria MA, Luna-Alvarez-Amezquita JA, Straface JI, Perez-Partida AM, Berarducci J, Armenta-Moreno JI, Garza-Cruz KJ, Espinola-Zavaleta N, Alexanderson-Rosas E (2022) Role of the antioxidant activity of melatonin in myocardial ischemia-reperfusion injury. Antioxidants 11(4):627–632. https://doi.org/10.3390/antiox11040627 - DOI - PubMed - PMC
-
- Bolli R (2001) Cardioprotective Function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33:1897–1918. https://doi.org/10.1006/jmcc.2001.1462 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials